Towards better patient outcomes - the cost-offset model Nancy JW Lewis Newsletter Article 17 February 2013 Pages: 3 - 4
Impact of new neurological drugs on US healthcare costs Newsletter Article 17 February 2013 Pages: 4 - 4
Debating appropriate, cost-effective prescribing for asthma Newsletter Article 17 February 2013 Pages: 5 - 6
Cost sharing ineffective in reducing healthcare expenditure Newsletter Article 17 February 2013 Pages: 6 - 6
Pneumococcal vaccination ‘illogical’ in HIV-infected patients Newsletter Article 17 February 2013 Pages: 6 - 6
Palliative antineoplastic therapy cost effective in GI cancers Newsletter Article 17 February 2013 Pages: 7 - 7
Is routine liver biopsy cost effective in methotrexate recipients? Newsletter Article 17 February 2013 Pages: 8 - 8
Costs of a screening programme for colorectal cancer Newsletter Article 17 February 2013 Pages: 8 - 8
Self-management reduces the economic burden of asthma Newsletter Article 17 February 2013 Pages: 9 - 9
Rapid test cost saving for diagnosing and treating group A strep Newsletter Article 17 February 2013 Pages: 9 - 9
Simple coronary risk factor screening strategies most cost effective Newsletter Article 17 February 2013 Pages: 10 - 11
Costly contraceptives prove more cost effective in long run Newsletter Article 17 February 2013 Pages: 12 - 12
Patient preferences important in angina management Newsletter Article 17 February 2013 Pages: 12 - 12
Alternative approach to the reuse of patients’ own drugs Newsletter Article 17 February 2013 Pages: 12 - 13
Assessing health values in patients with serious illness Newsletter Article 17 February 2013 Pages: 13 - 14
Annual rise of 2% predicted for European health spending Newsletter Article 17 February 2013 Pages: 15 - 15
French approach to drug cost control looks promising Newsletter Article 17 February 2013 Pages: 15 - 15